J&J MedTech reports one-year study results of peripheral IVL system

Investigational IVL system successfully treats severely calcified femoropopliteal disease in POWER PAD II pivotal study

Christopher Metzger presents during VIVA 2025 Christopher Metzger (Ballad Health CVA Heart Institute, Kingsport, USA) reported at the 2025 Vascular Interventional Advances (VIVA) conference (2–5 November, Las Vegas, USA) that the Pulse intravascular lithotripsy (IVL) system (Amplitude Vascular Systems) successfully treated severely calcified femoropopliteal disease in a pivotal investigational device exemption (IDE) study. The POWER PAD II study…

J&J MedTech reports one-year study results of peripheral IVL system

J&J MedTech has reported one-year outcomes from the DISRUPT BTK II trial of the Shockwave Peripheral intravascular lithotripsy (IVL) System.The post J&J MedTech reports one-year study results of peripheral IVL system appeared first on Medical Device Network.